Although high-altitude pulmonary edema has been the topic of research activity for a number of years, the basic mechanisms contributing to its formation remain incompletely understood. As a prototypical hypoxia- related lung injury, this condition is of interest because of its potential relationship to other conditions associated with hypoxia and lung injury, including adult respiratory distress syndrome (ARDS). In this proposal, we will present recent evidence suggesting that a stimulus directed at the epithelium (viral infection) may alter the response of the pulmonary vasculature to a second stimulus (hypoxia) and promote the formation of pulmonary edema. We will also present evidence that the effects of viral infection and hypoxia in the lung are mediated at least in part via the actions of the potent vasoconstrictor peptide, endothelin. We propose investigations testing the hypothesis that viral infections promote pulmonary edema formation in the hypoxic lung by altering the production of endothelin peptide and the expression of its receptors. Specifically, the aims of the proposed studies are: 1) to identify the molecular mechanisms by which viral infection augments hypoxia- induced increases in lung endothelin content by measuring expression of key molecules responsible for endothelin production and clearance from the lung; 2) to test the hypothesis that the combination of viral infection and hypoxia promotes pulmonary edema formation via an altered balance between ETA and ETB receptor populations, by using pharmacologic ET receptor antagonists as well as genetically altered animals; and 3) to identify using cell culture techniques the specific lung cell populations in which viral infection and hypoxia act to alter the expression of endothelin and its receptors, and to identify the mediators of those effects. The proposed research will better define the effects of viral respiratory infections and hypoxia on endothelin and its receptors in the lung, and may lead to new therapeutic avenues for acute lung injury, as well as for altitude-related illness.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL004424-04
Application #
6642163
Study Section
Special Emphasis Panel (ZHL1-CSR-K (M1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2000-09-01
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
4
Fiscal Year
2003
Total Cost
$128,250
Indirect Cost
Name
University of Colorado Denver
Department
Pediatrics
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Carpenter, Todd C; Stenmark, Kurt R (2004) Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis. Pediatr Infect Dis J 23:S33-40
McMahon, Timothy J; Moon, Richard E; Luschinger, Ben P et al. (2002) Nitric oxide in the human respiratory cycle. Nat Med 8:711-7
Carpenter, T C; Stenmark, K R (2001) Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. Am J Physiol Lung Cell Mol Physiol 281:L941-8